GC Pharma to provide COVID-19 treatment, free
In this May 17, 2020, photo released by Xinhua News Agency, a medical worker collects a sample for COVID-19 testing at the Tongji community in Shulan in northeastern China's Jilin Province. Authorities have tightened restrictions in parts of Jilin province in response to a local cluster. AP-YonhapBy Kim Yoo-chulGC Pharma, a leading South Korean biopharmaceutical company, said Monday it will provide a possible COVID-19 treatment “for free” for patients testing positive with the contagious disease.The company's plasma therapy ― GC5131A ― will be available for patients once its development is completed.“Other than the government's planned financial provision, GC Pharma will cover all costs after the commercialization of GC5131A. No prerequisites, condition, or distribution limit have been set and that means GC Pharma will cover all possible financial losses if COVID-19 spreads,” it said, adding the decision was a result of an “understanding” with its shareholders. “Treatments and drugs for contagious diseases such as COVID-19 should be intended